| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |